Fulcrum Therapeutics Announces Second Quarter 2022 Financial Results and Business Update

Go back to Fulcrum Therapeutics Announces Second Quarter 2022 Financial Results and Business Update
(NASDAQ: FULC) Delayed: 3.74 --0 (-0%)
Previous Close $3.74    52 Week High $ 
Open $3.74    52 Week Low $ 
Day High $3.74    P/E N/A 
Day Low $3.74    EPS $ 
Volume 100